Global Cell & Gene Therapy Manufacturing Market Analysis
January 03, 2023 07:35 ET
|
Global Market Estimates
Brooklyn, New York, Jan. 03, 2023 (GLOBE NEWSWIRE) -- According to a new market research report published by Global Market Estimates, the Global Cell & Gene Therapy Manufacturing Market is...
Alphageneron to Participate in Cell Therapy Durability Response Summit
August 17, 2022 10:30 ET
|
Alphageneron Pharmaceuticals
CAMBRIDGE, Mass., Aug. 17, 2022 (GLOBE NEWSWIRE) -- Alphageneron Pharmaceuticals, Inc. (“Alphageneron” or the “Company”), a clinical stage pharmaceutical company developing a diverse platform of...
Global Cell & Gene Therapy Raw Material Testing Market Size
July 04, 2022 08:07 ET
|
Global Market Estimates
Brooklyn, New York, July 04, 2022 (GLOBE NEWSWIRE) -- According to a new market research report published by Global Market Estimates, the Global Cell & Gene Therapy Raw Material Testing Market...
Recombinant Protein Market worth $3.93 Billion by 2030, Registering a CAGR of 10.12%
June 03, 2022 08:59 ET
|
STRATEGIC MARKET RESEARCH LLP
New York, United States, June 03, 2022 (GLOBE NEWSWIRE) -- Recombinant protein is regarded as a manipulated form of the native protein, which is generated in a variety of ways in order to increase...
Informa Pharma Intelligence and The American Society of Gene & Cell Therapy (ASGCT) Launches Gene, Cell & RNA Therapy Landscape Q1 2022 Quarterly Data Report
April 28, 2022 12:00 ET
|
Informa Business Intelligence
NEW YORK, April 28, 2022 (GLOBE NEWSWIRE) -- Informa Pharma Intelligence, the global business intelligence provider for the biopharma industry, and The American Society of Gene & Cell Therapy...
Alphageneron to Participate in the ROTH Virtual Healthcare Private Company Forum on June 28th, 2021
June 25, 2021 19:21 ET
|
Alphageneron Pharmaceuticals
CAMBRIDGE, Mass., June 25, 2021 (GLOBE NEWSWIRE) -- Alphageneron Pharmaceuticals, Inc. (“Alphageneron” or the “Company”), a privately-held clinical-stage biopharmaceutical company developing...
The Alliance for Regenerative Medicine Releases Q3 2019 Sector Report, Highlighting Industry Trends and Metrics
November 05, 2019 11:03 ET
|
Alliance for Regenerative Medicine
WASHINGTON, D.C., Nov. 05, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- The Alliance for Regenerative Medicine (ARM) today released its most recent quarterly sector report, offering an in-depth look...
The Alliance for Regenerative Medicine Announces Initial Slate of Presenting Companies at the Seventh Annual Cell & Gene Therapy Investor Day
February 07, 2019 12:21 ET
|
Alliance for Regenerative Medicine
WASHINGTON, D.C., Feb. 07, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- The Alliance for Regenerative Medicine (ARM) today announced the initial slate of presenting companies at its annual Cell...